Soligenix (SNGX) Long-Term Deferred Tax (2017 - 2023)
Soligenix's (SNGX) quarterly Long-Term Deferred Tax came in at $17867.0 in Q3 2023, down 11.84% YoY from $20266.0 in Q3 2022, and little changed on a QoQ basis from $17867.0 in Q2 2023.
Soligenix (SNGX) Long-Term Deferred Tax (2017 - 2023) Analysis & Trends
Soligenix (SNGX) has 5 years of Long-Term Deferred Tax data on file, last reported at $17867.0 in Q3 2023.
- Quarterly Long-Term Deferred Tax fell 11.84% year-over-year to $17867.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $17867.0 (down 11.84% YoY) and the FY2022 annual result came in at $20206.0, changed 0.3% from the prior year.
- Long-Term Deferred Tax steadied at $17867.0 in Q3 2023, from $17867.0 in the prior quarter.
- In the past five years, Long-Term Deferred Tax ranged from a high of $53523.0 in Q4 2020 to a low of $5796.0 in Q2 2021.
- A 4-year average of $21557.0 and a median of $20266.0 in 2021 frame the typical range for Long-Term Deferred Tax.
- Annual changes were most pronounced in 2021 — Long-Term Deferred Tax slumped 62.14% — and 2022, when it surged 249.65%.
- Tracing SNGX's Long-Term Deferred Tax over 4 years: stood at $53523.0 in 2020, then tumbled by 62.14% to $20266.0 in 2021, then fell by 0.3% to $20206.0 in 2022, then decreased by 11.58% to $17867.0 in 2023.
- The last three Long-Term Deferred Tax figures came in at $17867.0 (Q3 2023), $17867.0 (Q2 2023), and $20153.0 (Q1 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Soligenix | 6.45 Mn | 6.45 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 17,867.00 |
| Jun 30, 2023 | 17,867.00 |
| Mar 31, 2023 | 20,153.00 |
| Dec 31, 2022 | 20,206.00 |
| Sep 30, 2022 | 20,266.00 |
| Jun 30, 2022 | 20,266.00 |
| Mar 31, 2022 | 20,266.00 |
| Dec 31, 2021 | 20,266.00 |
| Sep 30, 2021 | 20,651.00 |
| Jun 30, 2021 | 5,796.00 |
| Dec 31, 2020 | 53,523.00 |
| Dec 31, 2017 | 14.00 Mn |